Clinical Trial Update: Study of the Functional Effects of Nusinersen in 5q-spinal Muscular Amyotrophy Adults (SMA Type 2 or 3 Forms) [NA]

View source ↗

Summary

An update on the functional effects of nusinersen in adults with 5q-spinal muscular atrophy (SMA Type 2 or 3). The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Muscular Atrophy

Drugs mentioned

• Spinraza (nusinersen)

Snippet

Sponsor: CHU de Reims | Conditions: Spinal Muscular Atrophy | NA | Status: COMPLETED